{
  "docId": "019de072-a06b-75fe-abfc-06d6c9b36d69",
  "docSlug": "20a8e4b0fa87449fed1951c46c728b45",
  "documentTitle": "argenx SE | Results Presentation Deck | 21 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 21,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-a06b-75fe-abfc-06d6c9b36d69/14",
  "deckHref": "/decks/019de072-a06b-75fe-abfc-06d6c9b36d69",
  "deckJsonHref": "/decks/019de072-a06b-75fe-abfc-06d6c9b36d69.json",
  "deckAnchorHref": "/decks/019de072-a06b-75fe-abfc-06d6c9b36d69#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.32,
        "w": 0.18,
        "x": 0.02,
        "y": 0.4
      },
      "kind": "image",
      "text": "advance immune thrombocytopenia study",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83d737c2-41de-4e99-987b-cf7261c70288",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.78,
        "x": 0.19,
        "y": 0.28
      },
      "kind": "list",
      "text": "Primary endpoint met: Statistically significant and clinically meaningful improvement in platelet counts over placebo. Meaningful patient benefit observed: Fast and robust platelet count improvement over placebo; Ability for every other week dosing confirmed. Favorable safety & tolerability observed: Chronic administration of VYVGART was well-tolerated; Safety profile consistent with previous clinical trials",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fdbe2862-dcd6-49ae-8f6e-3b2874b83ac9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.16,
        "w": 0.52,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "ADVANCE-IV Phase 3 Results Support Path Forward",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6dc91aed-9a0f-41a1-bc67-ff819e9d3ad2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}